Cornerstone Pharmaceuticals Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • PIPE
  • (Cancelled)

  • Latest Deal Amount
  • $50M

  • Investors
  • 7

Cornerstone Pharmaceuticals General Information

Description

Developer of metabolic oncology therapeutics designed to treat cancer patients. The company's therapeutics apply bio-energetic processes specific to cancer and provide altered cancer metabolism-directed therapies and novel, drugs and drug delivery technologies, enabling patients to avail of safe cancer treatments and oncology professionals to improve the safety and efficacy of cancer treatments, with minimal toxicity to healthy cells.

Contact Information

Formerly Known As
Rafael Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1 Duncan Drive
  • Cranbury, NJ 08512
  • United States
+1 (609)
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Services
Biotechnology
Corporate Office
  • 1 Duncan Drive
  • Cranbury, NJ 08512
  • United States
+1 (609)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cornerstone Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. PIPE 21-Jun-2021 $50M Cancelled Clinical Trials - Phase 2
12. Reverse Merger 21-Jun-2021 Cancelled Clinical Trials - Phase 2
11. Later Stage VC (Series C) Completed Clinical Trials - Phase 2
10. Secondary Transaction - Private 02-Mar-2017 Completed Clinical Trials - Phase 2
9. Later Stage VC 10-Nov-2016 Completed Clinical Trials - Phase 2
8. Grant 21-Jan-2015 Completed Clinical Trials - Phase 2
7. Later Stage VC (Series B) 29-Jan-2010 Completed Clinical Trials - Phase 2
6. Later Stage VC (Series A) 27-May-2009 Completed Clinical Trials - Phase 2
5. Secondary Transaction - Open Market 01-Feb-2008 $19.7M Cancelled Clinical Trials - Phase 2
4. Later Stage VC 23-Feb-2006 $1M $6.51M Completed Clinical Trials - Phase 2
To view Cornerstone Pharmaceuticals’s complete valuation and funding history, request access »

Cornerstone Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Cornerstone Pharmaceuticals’s complete cap table history, request access »

Cornerstone Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of metabolic oncology therapeutics designed to treat cancer patients. The company's therapeutics apply bio-ene
Drug Discovery
Cranbury, NJ
19 As of 2026

Philadelphia, PA
 

Philadelphia, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cornerstone Pharmaceuticals Competitors (109)

One of Cornerstone Pharmaceuticals’s 109 competitors is Spark Therapeutics, a Formerly VC-backed company based in Philadelphia, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Spark Therapeutics Formerly VC-backed Philadelphia, PA
Aro Biotherapeutics Venture Capital-Backed Philadelphia, PA
AnTolRx Formerly VC-backed Cambridge, MA
Immunitas Therapeutics Formerly VC-backed Boston, MA
Ability Pharma Private Equity-Backed Cerdanyola, Spain
You’re viewing 5 of 109 competitors. Get the full list »

Cornerstone Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cornerstone Pharmaceuticals Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
IDT (Newark) Holding Company Minority
New Jersey Economic Development Authority Government
Althea Partners Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 7 investors. Get the full list »

Cornerstone Pharmaceuticals FAQs

  • When was Cornerstone Pharmaceuticals founded?

    Cornerstone Pharmaceuticals was founded in 2000.

  • Where is Cornerstone Pharmaceuticals headquartered?

    Cornerstone Pharmaceuticals is headquartered in Cranbury, NJ.

  • What is the size of Cornerstone Pharmaceuticals?

    Cornerstone Pharmaceuticals has 19 total employees.

  • What industry is Cornerstone Pharmaceuticals in?

    Cornerstone Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Cornerstone Pharmaceuticals a private or public company?

    Cornerstone Pharmaceuticals is a Private company.

  • What is Cornerstone Pharmaceuticals’s current revenue?

    The current revenue for Cornerstone Pharmaceuticals is .

  • How much funding has Cornerstone Pharmaceuticals raised over time?

    Cornerstone Pharmaceuticals has raised $29.2M.

  • Who are Cornerstone Pharmaceuticals’s investors?

    , IDT (Newark), New Jersey Economic Development Authority, Althea Partners, and are 5 of 7 investors who have invested in Cornerstone Pharmaceuticals.

  • Who are Cornerstone Pharmaceuticals’s competitors?

    Spark Therapeutics, Aro Biotherapeutics, AnTolRx, Immunitas Therapeutics, and Ability Pharma are some of the 109 competitors of Cornerstone Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process